Feb 15 2013
Research and Markets has announced the addition of the "Biosensors in Medical Diagnostics - Global Strategic Business Report" report to their offering.
This report analyzes the worldwide markets for Biosensors in Medical Diagnostics in US$ Million by the following Product Segments: Medical Biosensors, Glucose Biosensors, Other Medical Biosensors, Environmental Biosensors, and Other Biosensors. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets.
The report profiles 89 players including major companies developing Biosensor-Based Devices such as Abbott Point of Care, Inc., Siemens Healthcare Diagnostics Inc., Animas Corporation, Lifescan, Inc., Medtronic Diabetes, Hoffman La Roche, Leading Developers of Biosensor Technology: AgaMatrix Inc., Cranfield Health, LifeSensors INC., M-Biotech, and Nova Biomedical Corporation.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. Executive Summary
1. GLOBAL MARKET OVERVIEW AND ANALYSIS
2. A RETROSPECTIVE
3. COMPETITIVE SCENARIO
4. PRODUCT OVERVIEW
5. APPLICATION AREAS
6. PRODUCT LAUNCHES
INNOVATIONS
7. RECENT INDUSTRY ACTIVITY
8. CORPORATE ACTIVITY IN THE RECENT PAST - A PERSPECTIVE BUILDER
9. TECHNOLOGY DEVELOPMENTS IN THE RECENT PAST - A PERSPECTIVE BUILDER
10. FOCUS ON SELECT PLAYERS
11. GLOBAL MARKET PERSPECTIVE
III. MARKET
1. THE UNITED STATES
2. CANADA
3. JAPAN
4. EUROPE
5. ASIA-PACIFIC
6. REST OF WORLD
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 89 (including Divisions/Subsidiaries - 102)
Source: http://www.researchandmarkets.com